Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cutis
|
October 26, 2012
Varicella-zoster virus in children immunized with the varicella vaccine
Gregory Chesnut, Damon McClain, Kenneth Galeckas
Cutis
|
April 27, 2013
Mees lines and Beau lines
Gregory Chesnut, Sarah Taylor, Eric Belin
Journal of the American Academy of Dermatology
|
May 15, 2010
Allergic contact dermatitis caused by lanolin (wool) alcohol contained in an emollient in three postsurgical patients
Josephine C Nguyen, Gregory Chesnut, William D James, et al.
Proteomics
|
December 8, 2022
Differentially expressed glycoproteins in pre- and post-digital rectal examination urine samples for detecting aggressive prostate cancer
Yuefan Wang, Tung-Shing Mamie Lih, Naseruddin Höti, et al.
Urology Practice
|
August 28, 2024
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic Efficacy
Jonathan Fainberg, Taehyoung Lee, Emily A Vertosick, et al.
Journal of Surgical Education
|
July 25, 2022
A Novel Expert Coaching Model in Urology, Aimed at Accelerating the Learning Curve in Robotic Prostatectomy
Jonathan Fainberg, Rand N Wilcox Vanden Berg, Gregory Chesnut, et al.
World Journal of Urology
|
March 13, 2022
Prospective quality of life in men choosing open vs. robotic radical prostatectomy: long-term results from a racially diverse multi-institutional database
Eyal Kord, Nate Jung, Brock Boehm, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate Cancer
Arwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
Nature Communications
|
March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes
Indu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.
The Lancet. Oncology
|
June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
Theodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cutis
|
October 26, 2012
Varicella-zoster virus in children immunized with the varicella vaccine
Gregory Chesnut, Damon McClain, Kenneth Galeckas
Cutis
|
April 27, 2013
Mees lines and Beau lines
Gregory Chesnut, Sarah Taylor, Eric Belin
Journal of the American Academy of Dermatology
|
May 15, 2010
Allergic contact dermatitis caused by lanolin (wool) alcohol contained in an emollient in three postsurgical patients
Josephine C Nguyen, Gregory Chesnut, William D James, et al.
Proteomics
|
December 8, 2022
Differentially expressed glycoproteins in pre- and post-digital rectal examination urine samples for detecting aggressive prostate cancer
Yuefan Wang, Tung-Shing Mamie Lih, Naseruddin Höti, et al.
Urology Practice
|
August 28, 2024
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic Efficacy
Jonathan Fainberg, Taehyoung Lee, Emily A Vertosick, et al.
Journal of Surgical Education
|
July 25, 2022
A Novel Expert Coaching Model in Urology, Aimed at Accelerating the Learning Curve in Robotic Prostatectomy
Jonathan Fainberg, Rand N Wilcox Vanden Berg, Gregory Chesnut, et al.
World Journal of Urology
|
March 13, 2022
Prospective quality of life in men choosing open vs. robotic radical prostatectomy: long-term results from a racially diverse multi-institutional database
Eyal Kord, Nate Jung, Brock Boehm, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate Cancer
Arwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
Nature Communications
|
March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes
Indu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.
The Lancet. Oncology
|
June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
Theodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
Page
of 2